NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Signal Bioscience

Signal Bioscience

Private
Ann Arbor, MichiganHealthcare & Life Scienceshttps://signalbioscience.com/

Last Round

Accelerator

May 26, 2026

Total Funding Raised

$1.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Signal Bioscience is a diagnostics and research tools company that develops multiplex polymerase chain reaction (PCR) chemistry technology to expand diagnostic testing capabilities on existing laboratory instruments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

multiplex PCRqPCRdPCRassay developmentdiagnostic panelsmolecular diagnosticsreagent chemistryIVDin vitro diagnosticsbiotech reagentslab-on-a-chipgenomic testingCRO servicesclinical lab testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Signal Bioscience Comparables

Compare Signal Bioscience with similar companies based on industry and business-model similarity.

Signal Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aplex Bio
82%
ChromaCode
78%
PCRassays
76%

Signal Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 26, 2026
Pre SeedMar 16, 2026
SeedMar 16, 2026

Key People

Founding team and executive leadership

John Cunningham

Chief Executive Officer

Executive Team

Signal Bioscience Investors

Notable investors and investment history

Signal Bioscience investors
InvestorRounds
BioTools InnovatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2026

    Received funding from BioTools Innovator.

  • Mar 16, 2026

    $1.2M raised in Pre Seed round

Signal Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Signal Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Signal Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersAnn Arbor, Michigan
Employee Range6
Year Founded2023
Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.